Debbie C. Crans

The Chemistry and Biochemistry of Vanadium and the Biological Activities Exerted by Vanadium Compounds

Ru(II) Compounds: Next-Generation Anticancer Metallotherapeutics?

Decavanadate (<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" altimg="si1.gif" overflow="scroll"><mml:mrow><mml:msub><mml:mrow><mml:mtext>V</mml:mtext></mml:mrow><mml:mrow><mml:mn>10</mml:mn></mml:mrow></mml:msub><mml:msubsup><mml:mrow><mml:mtext>O</mml:mtext></mml:mrow><mml:mrow><mml:mn>28</mml:mn></mml:mrow><mml:mrow><mml:mn>6</mml:mn><mml:mo>-</mml:mo></mml:mrow></mml:msubsup></mml:mrow></mml:math>) and oxovanadates: Oxometalates with many biological activities

Chemistry and insulin-like properties of vanadium(IV) and vanadium(V) compounds1This manuscript summarizes the presentation given at the symposium ‘Biological Aspects of Vanadium Chemistry — Chemistry, Biochemistry and Therapeutic Applications of Vanadium Compounds’ and recently communicated in original research articles. The original research articles describing the experimental details of this work are given in Refs: [1–5].1

Polyoxovanadates with emerging biomedical activities

Speciation of metal drugs, supplements and toxins in media and bodily fluids controls in vitro activities

Anti-diabetic effects of a series of vanadium dipicolinate complexes in rats with streptozotocin-induced diabetes

Effect of vanadium(IV) compounds in the treatment of diabetes: in vivo and in vitro studies with vanadyl sulfate and bis(maltolato)oxovandium(IV)

Organometallic and coordination rhenium compounds and their potential in cancer therapy

Novel Insights into the Mechanism of Inhibition of MmpL3, a Target of Multiple Pharmacophores in Mycobacterium tuberculosis

When Is Water Not Water? Exploring Water Confined in Large Reverse Micelles Using a Highly Charged Inorganic Molecular Probe

Effects of vanadium complexes with organic ligands on glucose metabolism: a comparison study in diabetic rats